Microbot Medical Raises CTO and CFO Base Salaries and Lifts Annual Bonus Caps to 50%

Reuters02-25 06:01
Microbot Medical Raises CTO and CFO Base Salaries and Lifts Annual Bonus Caps to 50%

Microbot Medical Inc. entered into new compensation amendments effective for fiscal 2026, raising CTO and Israel facilities GM Simon Sharon’s annual base salary to NIS 1,008,000 and CFO Rachel Vaknin’s to NIS 756,000, with each eligible for an annual bonus of up to 50% of base salary. The company also increased Chief Medical Officer Juan Diaz-Cartelle’s maximum annual bonus to up to 50% of base salary for fiscal 2026. Separately, Microbot authorized a special bonus of about $140,000 for CEO, President and Chairman Harel Gadot, in addition to bonuses under his existing employment agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-007900), on February 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment